Lexicon Pharmaceuticals, Inc.
LXRX
$1.88
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.41% | -59.56% | -55.12% | -55.15% | -45.21% |
| Total Receivables | -75.17% | -31.36% | -19.38% | -16.68% | 3,009.24% |
| Inventory | 37.31% | 21.65% | -75.16% | -71.28% | -60.89% |
| Prepaid Expenses | 0.00% | -33.80% | -39.08% | -51.45% | -52.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.32% | -58.61% | -54.38% | -54.78% | -32.59% |
|
|
|||||
| Total Current Assets | -24.32% | -58.61% | -54.38% | -54.78% | -32.59% |
| Net Property, Plant & Equipment | 27.64% | 25.49% | 32.79% | -7.74% | -3.43% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7,880.43% | 7,880.43% | 3,446.86% | 3,446.86% | -55.56% |
| Total Assets | -9.69% | -38.01% | -35.87% | -39.58% | -28.65% |
|
|
|||||
| Total Accounts Payable | -71.97% | -79.17% | -73.26% | -51.73% | 32.50% |
| Total Accrued Expenses | -55.81% | -60.55% | -41.70% | -26.40% | -15.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -96.19% | 430.81% | 26.21% | -29.59% | 3,238.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -91.06% | -53.88% | -39.74% | 24.97% | 373.07% |
|
|
|||||
| Total Current Liabilities | -91.06% | -53.88% | -39.74% | 24.97% | 373.07% |
| Long-Term Debt | -15.28% | -50.74% | -43.43% | -43.61% | -41.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 41.17% | 43.30% | 45.39% | -9.95% | -11.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -74.96% | -62.87% | -28.25% | -- |
| Total Liabilities | -62.23% | -49.20% | -39.86% | -27.92% | 36.06% |
|
|
|||||
| Common Stock & APIC | 4.89% | 0.59% | 0.53% | 0.50% | 0.57% |
| Retained Earnings | -1.31% | -2.56% | -3.55% | -6.45% | -9.77% |
| Treasury Stock & Other | 42.41% | -14.70% | -20.91% | -8.17% | -10.65% |
| Total Common Equity | 64.88% | -26.32% | -32.69% | -46.06% | -57.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 64.88% | -26.32% | -32.69% | -46.06% | -57.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 64.88% | -26.32% | -32.69% | -46.06% | -57.41% |
|
|
|||||